Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Harland

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Suramin for prostate carcinomaS J Harland
British Journal of Urology|June 1, 1992
Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992S J Harland
Lancet (London, England)|November 18, 2000
Conundrum of the hereditary component of testicular cancerS J Harland
British Journal of Urology|September 1, 1990
Re: The fate of G3pT1 bladder cancerS J Harland
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Aggressive superficial bladder cancerS J Harland
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 22, 2005
A second look at the pT1 G3 bladder tumourS J Harland
European Urology|January 1, 1997
The importance of continued endocrine treatment during chemotherapy of hormone-refractory prostate cancerD Chao, S J Harland
BJU International|November 2, 2002
Survival prospects after screen-detection of prostate cancerP W Nicholson, S J Harland
Clinical Pharmacology and Therapeutics|July 1, 1979
Identification and quantitation of hydrazine in the urine of patients treated with hydralazineJ A Timbrell, S J Harland
British Journal of Urology|August 1, 1989
The pT1 G3 bladder tumourB R Birch, S J Harland
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Suramin for prostate carcinomaS J Harland
British Journal of Urology|June 1, 1992
Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992S J Harland
Lancet (London, England)|November 18, 2000
Conundrum of the hereditary component of testicular cancerS J Harland
British Journal of Urology|September 1, 1990
Re: The fate of G3pT1 bladder cancerS J Harland
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Aggressive superficial bladder cancerS J Harland
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 22, 2005
A second look at the pT1 G3 bladder tumourS J Harland
European Urology|January 1, 1997
The importance of continued endocrine treatment during chemotherapy of hormone-refractory prostate cancerD Chao, S J Harland
BJU International|November 2, 2002
Survival prospects after screen-detection of prostate cancerP W Nicholson, S J Harland
Clinical Pharmacology and Therapeutics|July 1, 1979
Identification and quantitation of hydrazine in the urine of patients treated with hydralazineJ A Timbrell, S J Harland
British Journal of Urology|August 1, 1989
The pT1 G3 bladder tumourB R Birch, S J Harland
Pageof 7